嵌入式監控設備市場規模、佔有率和成長分析:按產品類型、技術、應用、最終用戶和地區分類-2026年至2033年產業預測
市場調查報告書
商品編碼
2130981

嵌入式監控設備市場規模、佔有率和成長分析:按產品類型、技術、應用、最終用戶和地區分類-2026年至2033年產業預測

Implanted Monitoring Devices Market Size, Share, and Growth Analysis, By Product Type (Cardiac Monitoring Devices, Neurological Monitoring Devices), By Technology (Wired, Wireless), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2024 年全球植入式監測設備市場價值為 98.4 億美元,預計到 2025 年將成長至 107.8 億美元,到 2033 年將成長至 224.6 億美元,在預測期(2026-2033 年)內複合年成長率為 9.6%。

全球植入式監測設備市場以創新微型感測器和遙測系統為特色,這些設備專為外科植入而設計,用於監測血糖值、心率和神經活動等關鍵生理參數。推動該市場發展的動力源於人們對持續、即時健康數據日益成長的需求,以改善疾病管理並減少就醫次數。生物相容性材料、無線電力傳輸技術和微型化技術的進步,已將曾經的專用設備轉變為必不可少的治療解決方案。監管支援和報銷機制在推動市場成長方面發揮著至關重要的作用,它們加快了核准流程並促進了保險覆蓋。此外,數據分析和預測演算法的進步正在推動軟體即服務 (SaaS) 模式的發展,使製造商能夠透過將雲端技術與設備硬體相結合,最佳化商機並提高患者依從性。

全球嵌入式監控設備市場的成長要素

慢性病盛行率的不斷上升推動了對持續生理監測的需求,促使醫療專業人員積極部署可植入式設備,以提供即時資訊並減少患者頻繁就醫的需求。隨著患者積極主動管理自身健康,醫療服務提供者正致力於研發能夠早期發現併發症的技術,最終改善患者預後並減輕醫療系統的長期負擔。這種以患者為中心的醫療模式正在加速植入式技術在臨床實踐中的應用和推廣,同時也激勵製造商開發更人性化、更具創新性的技術。此外,這一趨勢也促使保險公司認知到長期成本節約的潛力,從而擴大了這些設備的保險覆蓋範圍。

全球植入式監測設備市場的限制因素

植入手術的高昂費用是植入式監測設備廣泛應用的主要障礙,尤其是在對成本高度敏感的醫療體系中。專業手術團隊、手術室使用以及術後護理的需求進一步加重了初始經濟負擔,這可能會阻礙患者和保險公司採用這些技術。預算限制通常優先考慮侵入性較小的方案,導致醫療服務提供者選擇提供類似臨床益處的外部穿戴式裝置。這種經濟挑戰進一步限制了市場擴張,尤其是在新興市場,這些市場往往缺乏先進醫療技術的資金支持。

全球嵌入式監控設備市場趨勢

受遠端監測技術融合的推動,全球植入式監測設備市場正經歷顯著成長。醫療服務提供者正擴大將這些設備連接到雲端平台,使臨床醫生能夠無縫存取即時生理數據。這一趨勢有助於加強疾病預防管理,減少患者再入院,並顯著提高患者的生活品質。此外,保險公司正優先考慮具有成本效益的遠距醫療解決方案,而製造商則正在整合安全通訊模組並遵守互通性標準。隨著寬頻在全球的普及,循環系統監測生態系統正在不斷發展,並進一步擴展到包括心臟病學、神經病學和代謝性疾病在內的各個醫學專科領域。

目錄

介紹

  • 調查目的
  • 市場定義和範圍

調查方法

  • 研究過程
  • 二級資料和一級資料的方法
  • 市場規模估算方法

執行摘要

  • 全球市場展望
  • 市場主要亮點
  • 細分市場概覽
  • 競爭環境概述

市場動態及展望

  • 總體經濟指標
  • 促進者和機會
  • 抑制因素和挑戰
  • 供給面趨勢
  • 需求面趨勢
  • 波特的分析和影響

關鍵市場分析

  • 關鍵成功因素
  • 影響市場的因素
  • 主要投資機會
  • 生態系測繪
  • 2025年市場魅力指數
  • PESTLE分析
  • 監理情勢

全球嵌入式監控設備市場規模:依產品類型分類

  • 心臟監測設備
  • 神經監測設備
  • 血糖監測設備
  • 壓力監測裝置
  • 其他嵌入式監控設備

全球嵌入式監控設備市場規模:依技術分類

  • 有線型
  • 無線的

全球嵌入式監控設備市場規模:按應用領域分類

  • 心血管疾病
  • 糖尿病管理
  • 神經病變
  • 慢性病監測
  • 其他

全球嵌入式監控設備市場規模:依最終用戶分類

  • 醫院
  • 門診手術中心
  • 專科診所

全球嵌入式監控設備市場規模:按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

競爭資訊

  • 前五大公司對比
  • 主要公司2025年的市場定位
  • 主要市場公司採取的策略
  • 近期市場趨勢
  • 企業市場占有率分析,2025 年
  • 主要公司的完整公司簡介
    • 公司詳情
    • 產品系列分析
    • 按細分市場進行企業市佔率分析
    • 銷售收入年比比較(2023-2025 年)

主要公司簡介

  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Koninklijke Philips NV
  • GE HealthCare Technologies Inc.
  • Siemens Healthineers AG
  • BIOTRONIK, Inc.
  • MicroPort Scientific Corporation
  • LivaNova PLC
  • Baxter International Inc.
  • Edwards Lifesciences Corporation
  • iRhythm Technologies, Inc.
  • Masimo Corporation
  • Nihon Kohden Corporation
  • OSI Systems, Inc.
  • Stryker Corporation
  • Dexcom, Inc.
  • Inspire Medical Systems, Inc.
  • Merit Medical Systems, Inc.

結論與建議

簡介目錄
Product Code: SQMIG35A4428

Global Implanted Monitoring Devices Market size was valued at USD 9.84 Billion in 2024 and is poised to grow from USD 10.78 Billion in 2025 to USD 22.46 Billion by 2033, growing at a CAGR of 9.6% during the forecast period (2026-2033).

The global market for implanted monitoring devices features innovative miniature sensors and telemetry systems designed for surgical implantation to monitor vital physiological parameters like glucose levels, cardiac rhythms, and neural activity. This market is fueled by the increasing demand for continuous and real-time health data to enhance disease management and minimize hospital visits. Advances in biocompatible materials, wireless power technologies, and miniaturization have transitioned these once-specialized devices into essential therapeutic solutions. Regulatory support and reimbursement mechanisms are pivotal in propelling market growth by expediting approvals and encouraging insurance coverage. Furthermore, enhancements in data analytics and predictive algorithms drive the development of software-as-a-service offerings, allowing manufacturers to combine cloud technology with device hardware, thereby optimizing revenue opportunities and boosting patient compliance.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Implanted Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Implanted Monitoring Devices Market Segments Analysis

Global implanted monitoring devices market is segmented by product type, technology, application, end user and region. Based on product type, the market is segmented into Cardiac Monitoring Devices, Neurological Monitoring Devices, Glucose Monitoring Devices, Pressure Monitoring Devices and Other Implanted Monitoring Devices. Based on technology, the market is segmented into Wired and Wireless. Based on application, the market is segmented into Cardiovascular Disorders, Diabetes Management, Neurological Disorders, Chronic Disease Monitoring and Others. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Implanted Monitoring Devices Market

The increasing prevalence of chronic diseases is fueling the demand for continuous physiological monitoring, leading healthcare professionals to embrace implanted devices that offer real-time insights and eliminate the need for frequent hospital visits. As patients aim for proactive management of their conditions, healthcare providers focus on technologies that facilitate early detection of complications, ultimately enhancing patient outcomes and alleviating the long-term burden on healthcare systems. This shift towards patient-centric care boosts the acceptance of implantable technologies, driving clinical integration and encouraging manufacturers to develop more user-friendly innovations. Furthermore, this trend prompts insurers to acknowledge potential long-term cost savings, thereby enhancing coverage for these devices.

Restraints in the Global Implanted Monitoring Devices Market

The high costs associated with implantation procedures pose a considerable obstacle to the broad adoption of implanted monitoring devices, particularly in healthcare systems that are sensitive to expenses. The requirement for specialized surgical teams, access to operating rooms, and subsequent post-operative care adds to the significant initial financial burden, which may deter both patients and insurers from embracing these technologies. Budgetary constraints often favor less invasive options, leading healthcare providers to choose external wearable devices that offer similar clinical advantages. This economic challenge further restricts market expansion, especially in emerging markets where funding for advanced medical technologies is frequently inadequate.

Market Trends of the Global Implanted Monitoring Devices Market

The Global Implanted Monitoring Devices market is experiencing significant growth driven by the integration of remote monitoring technologies. Healthcare providers are increasingly connecting these devices to cloud platforms, enabling clinicians to access real-time physiological data seamlessly. This trend enhances proactive disease management, diminishes hospital readmissions, and significantly improves patient quality of life. Additionally, payors are prioritizing cost-efficient remote care solutions, leading manufacturers to incorporate secure communication modules and adhere to interoperable standards. As global broadband coverage expands, the continuous monitoring ecosystem is evolving, promoting wider adoption across various medical specialties, including cardiology, neurology, and metabolic diseases.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Implanted Monitoring Devices Market Size by Product Type & CAGR (2026-2033)

  • Market Overview
  • Cardiac Monitoring Devices
  • Neurological Monitoring Devices
  • Glucose Monitoring Devices
  • Pressure Monitoring Devices
  • Other Implanted Monitoring Devices

Global Implanted Monitoring Devices Market Size by Technology & CAGR (2026-2033)

  • Market Overview
  • Wired
  • Wireless

Global Implanted Monitoring Devices Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Cardiovascular Disorders
  • Diabetes Management
  • Neurological Disorders
  • Chronic Disease Monitoring
  • Others

Global Implanted Monitoring Devices Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Global Implanted Monitoring Devices Market Size & CAGR (2026-2033)

  • North America (Product Type, Technology, Application, End User)
    • US
    • Canada
  • Europe (Product Type, Technology, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Technology, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Technology, Application, End User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Technology, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronik SE & Co. KG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE HealthCare Technologies Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BIOTRONIK, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • iRhythm Technologies, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Masimo Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nihon Kohden Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OSI Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dexcom, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inspire Medical Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations